(NASDAQ: LEGN) Legend Biotech's forecast annual revenue growth rate of 50.72% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Legend Biotech's revenue in 2025 is $627,241,000.On average, 9 Wall Street analysts forecast LEGN's revenue for 2025 to be $372,514,959,308, with the lowest LEGN revenue forecast at $337,548,926,440, and the highest LEGN revenue forecast at $425,913,364,966. On average, 8 Wall Street analysts forecast LEGN's revenue for 2026 to be $575,071,465,847, with the lowest LEGN revenue forecast at $532,006,460,150, and the highest LEGN revenue forecast at $617,281,592,197.
In 2027, LEGN is forecast to generate $790,823,934,003 in revenue, with the lowest revenue forecast at $653,625,705,247 and the highest revenue forecast at $929,250,180,429.